Nanocoating technology for sweet protein stabilization in shelf-stable beverages

Overview

This research proposes the application of advanced nanocoating techniques to improve the stability and functional performance of sweet proteins, particularly Brazzein, in shelf-stable beverage formulations. Sweet proteins represent a promising natural alternative to traditional caloric and artificial sweeteners, but they face significant technical barriers when used in acidic, thermally processed beverages. By applying nanoscale surface modifications, the project aims to protect these proteins from degradation caused by low pH environments and high-temperature processing, enabling their use in commercially relevant beverage applications.

The solution is designed for beverage manufacturers and food technology companies seeking natural, health-conscious sweetener options that can withstand industrial processing conditions and maintain consistent quality over extended shelf life.

Technical specifications

Core technology:

• Nanocoating applies ultra-thin layers of nanomaterials onto the surface of sweet proteins at the atomic or molecular level
• Surface modification alters the protein's external properties to resist environmental stressors without altering its core sweetening function

Why Brazzein:

• Higher stability in low pH environments compared to other sweet proteins such as Monellin and Thaumatin
• Robust thermal stability suitable for hot filling and aseptic processing conditions
• Available safety and toxicology data supporting its suitability for consumption
• Efficient production through recombinant expression in host organisms such as E. coli

Validation approach:

• Characterization of modified Brazzein for safety, taste profile, solubility, and stability under target beverage conditions
• Accelerated and real-time shelf-life testing targeting a minimum of six months stability
• Regulatory pathway investigation for markets including the United States, Canada, and Europe

Technology readiness level

The research is at an early-to-mid stage of development. Preliminary feasibility studies have been completed involving surface modification of multiple sweet proteins including Brazzein, Monellin, and Thaumatin. Future work will focus on selecting Brazzein as the primary candidate, conducting rigorous characterization, performing shelf-life validation, and establishing a regulatory pathway for market entry in key regions.